Concepedia

Susan Lerner

SL

95

Publications

11.6K

Citations

51

H-Index

1984

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California San Diego

Susan Lerner is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and immunology.

ORCID

Top concepts

Publications per year

1984–2016

95

Publications

95

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

Michael J. Keating, Susan O’Brien, Maher Albitar et al. · Journal of Clinical Oncology · 2005 · 947 citations · Full text

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Constantine S. Tam, Susan O’Brien, William G. Wierda et al. · Blood · 2008 · 687 citations · Full text

Rituximab Dose-Escalation Trial in Chronic Lymphocytic Leukemia

Susan O’Brien, Hagop M. Kantarjian, Deborah A. Thomas et al. · Journal of Clinical Oncology · 2001 · 588 citations

Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia

William G. Wierda, Susan O’Brien, Sijin Wen et al. · Journal of Clinical Oncology · 2005 · 521 citations

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

Sherif Ibrahim, Michael J. Keating, Kim‐Anh Do et al. · Blood · 2001 · 449 citations · Full text

Rows per page

1–5 of 95